The correlation shown in our study between immunohistochemical loss of MMR protein expression and recurrent gliomas is in line with previous papers demonstrating a different expression profile of MMR proteins between diagnosis and recurrence disease. The gene discussed is MRC1; the disease is central nervous system cancer.